Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients
- Voisin Céline
- 2 hours ago
- 1 min read
The Ecosystem Breakfast took place on December 16, 2025, moderated by Céline Capéra , Head of Sales, IntegraGen, and Charles Marcaillou , Head of R&D, IntegraGen.
and Séverine Matin-Lannerée , PhD, Head of Quality, IntegraGen The replay of the presentation on the topic " Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients " is now available .
Access the replay
